820 THERAPEUTIC DRUG MONITORING OF TELAPREVIR IN CHRONIC HEPATITIS C PATIENTS RECEIVING TELAPREVIR-BASED TRIPLE THERAPY IS USEFUL FOR PREDICTING VIROLOGICAL RESPONSE AND AVOIDING TOXIC DRUG-EXPOSURE